Tietueen sitaatit

APA-viite (7. p.)
Gomez-Gomez, E., Sorribas, S. M., Valero-Rosa, J., Blanca, A., Mesa, J., Salguero, J., . . . Anglada-Curado, F. J. (2021). Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy? MDPI AG.
Chicago-viite (17. p.)
Gomez-Gomez, Enrique, Sara Moreno Sorribas, Jose Valero-Rosa, Ana Blanca, Juan Mesa, Joseba Salguero, Julia Carrasco-Valiente, Daniel López-Ruiz, ja Francisco José Anglada-Curado. Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy? MDPI AG, 2021.
MLA-viite (9. p.)
Gomez-Gomez, Enrique, et al. Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy? MDPI AG, 2021.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.